
Isorifam150 mg+100
ACME Laboratories Ltd.
Rifampicin + Isoniazid is a fixed-dose combination of two first-line antitubercular agents used, as part of a physician-directed multi-drug regimen, in the treatment of tuberculosis (TB).
Rifampicin + Isoniazid is a fixed-dose combination of two first-line antitubercular agents used, as part of a physician-directed multi-drug regimen, in the treatment of tuberculosis (TB).
Rifampicin + Isoniazid must never be used as monotherapy for active tuberculosis. It is appropriate only as part of a complete, physician-supervised multi-drug antitubercular regimen, because single-agent use rapidly selects for drug-resistant M. tuberculosis, including multidrug-resistant TB (MDR-TB).
Rifampicin + Isoniazid dosing is weight-based and must be individualized by a physician managing tuberculosis treatment, generally following WHO or national tuberculosis programme guidance. Doses below are for the rifampicin + isoniazid combination used in the continuation phase (and, where appropriate, throughout treatment) alongside other antitubercular agents as directed.
| Body weight | Typical daily dose (Rifampicin + Isoniazid) |
|---|---|
| < 50 kg | Rifampicin 450 mg + Isoniazid 300 mg once daily (as appropriate fixed-dose tablet combination/number of tablets) |
| ≥ 50 kg | Rifampicin 600 mg + Isoniazid 300 mg once daily (as appropriate fixed-dose tablet combination/number of tablets) |
In children, dosing is calculated per kilogram of body weight (approximately rifampicin 10–20 mg/kg and isoniazid 7–15 mg/kg per day, within WHO-recommended ranges and maximum daily doses), using formulations appropriate for the child's weight band, under specialist supervision.
Use with caution and reduced total daily dose (e.g., not exceeding about 8 mg/kg/day of the combination) in patients with hepatic impairment; active/severe liver disease is a contraindication (see Contraindications).
Take Rifampicin + Isoniazid exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice. Completing the entire prescribed course is essential to cure tuberculosis and prevent the emergence of drug-resistant disease.
As with any medicine, Rifampicin + Isoniazid can cause side effects. Report any of the following to your physician.
Seek urgent medical care for signs of a severe allergic reaction (swelling of the face/throat, difficulty breathing) or severe skin reactions (blistering, peeling skin).
Rifampicin + Isoniazid is contraindicated in patients with:
Rifampicin + Isoniazid should also not be co-administered with certain ritonavir-boosted protease inhibitor antiretroviral combinations because of the risk of severe hepatotoxicity through drug interaction; your physician will select an appropriate regimen if you are on antiretroviral therapy.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.